orphenadrine and nicotine

orphenadrine has been researched along with nicotine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Funcke, AB; Lavy, UI; Mulder, D; Nauta, WT; Timmerman, H; van Beek, MC; van Hell, G1

Other Studies

4 other study(ies) available for orphenadrine and nicotine

ArticleYear
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Pharmacological properties of tofenacine hydrochloride: N-methyl-2-[(o-methyl-a-phenylbenzyl)oxy]ethylamine hydrochloride.
    Archives internationales de pharmacodynamie et de therapie, 1969, Volume: 177, Issue:1

    Topics: Adjuvants, Anesthesia; Adrenergic alpha-Antagonists; Animals; Anticonvulsants; Blood Pressure; Body Temperature; Central Nervous System; Coronary Vessels; Diuretics; Drug Synergism; Ethylamines; Female; Guinea Pigs; Hexobarbital; Histamine H1 Antagonists; Locomotion; Male; Mice; Motor Activity; Nicotine; Norepinephrine; Orphenadrine; Parasympatholytics; Pupil; Rats; Respiration; Salivation; Tetrabenazine; Tremorine

1969